Voizbose M 500mg/0.2mg Tablet SR
Marketer
Ellanjey Lifesciences
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Voizbose M 500mg/0.2mg Tablet SR
Diabexe-M 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe-M should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are generally transient and self-limiting. Persistent or concerning side effects necessitate consultation with your physician, who can offer management strategies. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your doctor.
Primary Ingredients of Voizbose M 500mg/0.2mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Voizbose M 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voizbose M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voizbose M 500mg/0.2mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.
Common Side effects of Voizbose M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voizbose M 500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Voizbose M 500mg/0.2mg Extended-Release Tablet with food.
How Voizbose M 500mg/0.2mg Tablet SR works:
Extended-release Voizbose M tablets (500mg/0.2mg) contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Voizbose M 500mg/0.2mg Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Voizbose M 500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voizbose M 500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
The extended-release Voizbose M 500mg/0.2mg tablet generally does not impair driving ability. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Voizbose M 500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Voizbose M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Voizbose M 500mg/0.2mg Tablet SR :
Should you forget a Voizbose M 500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voizbose M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently